Senti Biosciences
SNTI
Senti Biosciences (SNTI) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Chardan Capital | Maintained | Buy | $12.00 from $11.00 | May 15, 2026 |
| Chardan Capital | Maintained | Buy | $11.00 from $13.00 | Mar 30, 2026 |
| Chardan Capital | Maintained | Buy | $13.00 from $12.00 | Dec 9, 2025 |
| Leerink Partners | Initiated Coverage | Outperform | $6.00 | Nov 21, 2025 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $12.00 | Oct 14, 2025 |
| Chardan Capital | Maintained | Buy | $12.00 | Aug 8, 2025 |
| Chardan Capital | Maintained | Buy | $12.00 | Jun 12, 2025 |
| Laidlaw & Co. | Initiated Coverage | Buy | $15.00 | Jun 6, 2025 |
| Chardan Capital | Maintained | Buy | $12.00 | May 2, 2025 |
| Chardan Capital | Maintained | Buy | $12.00 from $10.00 | Dec 4, 2024 |
| Chardan Capital | Maintained | Buy | $10.00 | Dec 2, 2024 |
| Chardan Capital | Maintained | Buy | $6.00 | Aug 15, 2023 |
| Chardan Capital | Maintained | Buy | $6.00 from $7.00 | May 11, 2023 |
| Morgan Stanley | Maintained | Equal-Weight | $2.00 from $3.00 | Mar 24, 2023 |
| Chardan Capital | Maintained | Buy | $7.00 from $8.00 | Mar 23, 2023 |
Frequently asked questions
What is the latest analyst rating on SNTI?
On May 15, 2026, Chardan Capital maintained Senti Biosciences at Buy with a price target of $12.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.